Advertisement
Advertisement
Trending on Urology Times
1
Phase 3 trial launches of CAIX-targeted radiopharmaceutical for ccRCC
2
Residual stone volume outperforms stone-free rate as risk marker
3
Challenges with Integrating Real-World Evidence for ARPI Use in mCSPC
4
Evaluating Real-World Evidence and Clinical Endpoints in mCSPC
5